Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...
Lively said patients’ primary concerns about prescriptions are cost and convenience/access. The CareArc pharmacy will enable ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
House Democrats want to know what the Trump administration plans to do after it rescinded a Biden-era executive order to ...
House Democrats press the Trump administration for clarity on how the president's order rescinding Biden's drug cost ...
AbbVie forecast 2025 profit above estimates on Friday, as strong sales of its newer immunology drugs Skyrizi and Rinvoq make up for a steep decline in those of Humira, its flagship rheumatoid ...